✦ LIBER ✦

The use of in vitro bone marrow toxicity to predict clinical MTD in humans

Book ID: 117659358
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 134 KB
Volume: 38
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(02)80665-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Toxicity of cytostatic drugs to normal b

Toxicity of cytostatic drugs to normal bone marrow cells in vitro

✍ Britt Sundman-Engberg; Ulf Tidefelt; Christer Paul 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 442 KB

Generation of clinical grade human bone

Generation of clinical grade human bone marrow stromal cells for use in bone regeneration

✍ Robey, Pamela G.; Kuznetsov, Sergei A.; Ren, Jiaqiang; Klein, Harvey G.; Sabatin 📂 Article 📅 2015 🏛 Elsevier Science 🌐 English ⚖ 575 KB

Effect of cytokines on the toxicity of c

Effect of cytokines on the toxicity of cytostatic drugs to normal bone marrow cells in vitro

✍ Britt Sundman-Engberg; Christer Paul; Ulf Tidefelt 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 331 KB

Comparison of dideoxynucleoside drugs (D

Comparison of dideoxynucleoside drugs (DDI and zidovudine) and induction of hematopoietic toxicity using normal human bone marrow cells in vitro

✍ Vincent S. Gallicchio; Nedda K. Hughes; Kam-Fai Tse 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 496 KB

In vitro pharmacological purging of huma

In vitro pharmacological purging of human bone marrow is enhanced by the use of lonidamine

✍ Paolo De Fabritiis; Antonella Sandrelli; Alfredo Covelli; Francesca Simone; Lidi 📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 759 KB

The use of colony stimulating factors in

The use of colony stimulating factors in clinical bone marrow transplantation

✍ Robert S Negrin; Peter L Greenberg 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 508 KB

The use of colony stimulating factors in clinical bone marrow transplantation is rapidly evolving. Both granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor have shown efficacy in bone marrow transplant patients in accelerating the rate of myeloid recovery. The